Hydrate inhibitors are used to prevent or reduce gas hydrate formation. Gas hydrates are formed in offshore production systems under low temperature and high pressure conditions. These hydrates block pipelines, drill strings, BOP’s, by forming plugs, and cause flow assurance issues. Hydrate inhibitors are used where mechanical methods such as insulated flow line and active heating are not feasible options. However, political instability and low price of oil is a major factor negatively affecting growth of the global hydrate inhibitors market.
Market Dynamics
Increasing demand for natural gas and oil is expected to boost the global hydrate inhibitors market growth. Global demand for energy is increasing rapidly. Moreover, world natural gas consumption is expected to increase by 43% from 2015 to 2040 according to the International Energy Outlook 2017, as natural gas continues to be the fuel for electric power generation and for application in industrial sectors. Electric power and industrial sector uses around 75% of the natural gas of the projected increase in total consumption between 2015 and 2040.
By region, North America held a major market share of 58% in 2017. Middle East and Europe held significant market share in the global hydrate inhibitors market.
Europe is a lucrative market for hydrate inhibitors with significant demand due to high offshore oil production from the region in 2017 and it is expected to increase during forecast period. For instance, according to the EU, 567 million barrels of offshore oil had been produced in the U.K. in 2012. Furthermore, 95 million barrels of offshore oil and 105 million barrels of offshore gas production was recorded in Norway in 2012, according to the EU.
Key features of the study:
This report provides in-depth analysis of hydrate inhibitors market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2025), considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global hydrate inhibitors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study includes Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
The global hydrate inhibitors market report caters to various stakeholders in this industry including investors, suppliers, hydrate inhibitors manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the hydrate inhibitors market
Detailed Segmentation:
Global Hydrate Inhibitors Market, By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Global Hydrate Inhibitors Market, By Geography:
North America
U.S.
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Canada
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Europe
U.K.
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Germany
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
France
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Italy
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Spain
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Russia
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Rest of Europe
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Asia Pacific
China
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
India
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Japan
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
ASEAN
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Australia
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
South Korea
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Rest of Asia Pacific
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Latin America
Brazil
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Argentina
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Mexico
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Rest of Latin America
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Middle East
GCC
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Israel
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Rest of Middle East
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Africa
Northern Africa
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Central Africa
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
South Africa
By Inhibitor Type:
Thermodynamic Inhibitors
Methanol
Mono Ethylene Glycol (MEG)
Low Dosage Hydrate Inhibitors (LDHI’s)
Anti-Agglomeration Inhibitors/Surfactants
Quaternary Ammonium Compounds
Amides
Bio-surfactants
Kinetic Inhibitors
Polyvinylcaprolactam
Polyvinylpyrrolidone
Polyethyloxazoline
N-methyl-N-vinylacetamide
Tetra pentyl ammonium bromide
Butoxy-ethanol
Emulsifiers
Hybrid
Company Profiles
Halliburton*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans
Ashland Global Specialty Chemicals Inc.
Ecolab Inc.
Baker Hughes Inc.
Innospec Inc.
JSC Gazprom Neftekhim Salavat
BASF SE
Evonik Industries AG
Clariant AG
GasHydrate LLC
Schlumberger Limited
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Inhibitor Type
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Supply Side Drivers
o Demand Side Drivers
o Economic Drivers
o Restraints
o Market Opportunities
o Regulatory Scenario
o Industry Trend
o Merger and Acquisitions
o New Product Approvals/Launch
o Promotion and Marketing Initiatives
o Cost Tier Down Analysis
4. Global Hydrate Inhibitors Market, By Inhibitor Type, 2018- 2025 (US$ Million)
o Introduction
o Market Share Analysis, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, 2018 - 2025
o Segment Trends
o Thermodynamic Inhibitors
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2025, (US$ Million)
o Low Dosage Hydrate Inhibitors (LDHI's)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2025, (US$ Million)
o Hybrid
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2018 - 2025, (US$ Million)
5. Global Hydrate Inhibitors Market, By Region, 2018- 2025 (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, For Regions, 2018 - 2025
o North America
o Market Share Analysis, By Country, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, By Country, 2018 - 2025
o U.S.
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Canada
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Europe
o Market Share Analysis, By Country, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, By Country, 2018 - 2025
o U.K.
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Germany
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o France
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Italy
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Spain
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Russia
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Rest of Europe
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Asia Pacific
o Market Share Analysis, By Country, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, By Country, 2018 - 2025
o China
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o India
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Japan
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o ASEAN
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Australia
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o South Korea
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Rest of Asia Pacific
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Latin America
o Market Share Analysis, By Country, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, By Country, 2018 - 2025
o Brazil
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Argentina
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Mexico
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Rest of Latin America
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Middle East
o Market Share Analysis, By Country, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, By Country, 2018 - 2025
o GCC
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Israel
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Rest of Middle East
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Africa
o Market Share Analysis, By Country, 2017 and 2025 (%)
o Y-o-Y Growth Analysis, By Country, 2018 - 2025
o Northern Africa
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o Central Africa
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
o South Africa
o Country Trends
o Market Size and Forecast, By Inhibitor Type, 2018- 2025 (US$ Million)
6. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
o Halliburton
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Ashland Global Specialty Chemicals Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Ecolab Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Baker Hughes Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Innospec Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o JSC Gazprom Neftekhim Salavat
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o BASF SE
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Evonik Industries Ag
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Clariant AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o GasHydrate LLC
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Schlumberger Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Analyst Views
7. Section
o References
o Research Methodology
o About us and Sales Contact
* Browse 150 market data tables* and 90 figures* on "Hydrate Inhibitors Market" - Global forecast to 2025.
Request Discount 
Inquire Before Buy
